檢索結果 - Matthias Christgen

Refine Results
  1. 1
    Lobular breast cancer: molecular basis, mouse and cellular models

    Lobular breast cancer: molecular basis, mouse and cellular models 由 Matthias Christgen, Patrick W.B. Derksen

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Clinical validity and clinical utility of Ki67 in early breast cancer

    Clinical validity and clinical utility of Ki67 in early breast cancer 由 Hans Kreipe, Nadia Harbeck, Matthias Christgen

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes

    Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes 由 Claudia Pommerenke, Stefan Nagel, Josephine Haake, Anne Leena Koelz, Matthias Christgen, Laura Steenpaß, Sonja Eberth

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    High frequency of lobular breast cancer in distant metastases to the orbit

    High frequency of lobular breast cancer in distant metastases to the orbit 由 Mieke Raap, Wiebke Antonopoulos, Maximilian Ernst Dämmrich, Henriette Christgen, Diana Steinmann, Florian Länger, Ulrich Lehmann, Hans Kreipe, Matthias Christgen

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

    Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors 由 Matthias Christgen, Gábor Cserni, Giuseppe Floris, Caterina Marchiò, Lounes Djerroudi, Hans Kreipe, Patrick W.B. Derksen, Anne Vincent‐Salomon

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements

    E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements 由 Matthias Christgen, Stephan Bartels, Jana Lisa van Luttikhuizen, Janin Bublitz, Luisa Rieger, Henriette Christgen, Helge Stark, Bjoern Sander, Ulrich Lehmann, Doris Steinemann, Patrick W.B. Derksen, Hans Kreipe

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions

    Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions 由 George Sflomos, Koen Schipper, Thijs Koorman, Amanda Fitzpatrick, Steffi Oesterreich, Adrian V. Lee, Jos Jonkers, Valerie G. Brunton, Matthias Christgen, Clare M. Isacke, Patrick W.B. Derksen, Cathrin Brisken

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial

    Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prosp... 由 Kolberg-Liedtke, Cornelia, Oleg, Gluz, Fred, Heinisch, Friedrich, Feuerhake, Hans, Kreipe, Michael, Clemens, Benno, Nuding, Wolfram, Malter, Toralf, Reimer, Rachel, Wuerstlein, Monika, Graeser, Steve, Shak, Ulrike, Nitz, Ronald, Kates, Matthias, Christgen, Nadia, Harbeck

    出版 2020
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  9. 9
    Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer

    Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer 由 Jeroen F. Vermeulen, Robert A. H. van de Ven, Cigdem Ercan, Petra van der Groep, Elsken van der Wall, Peter Bult, Matthias Christgen, Ulrich Lehmann, Juliet M. Daniel, P. J. van Diest, Patrick W.B. Derksen

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage

    Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage 由 Max A. K. Rätze, Lotte Enserink, Noboru Ishiyama, Sven van Kempen, Christina H. J. Veltman, Isaäc J. Nijman, Wisse E. Haakma, Carlos Caldas, René Bernards, P. J. van Diest, Matthias Christgen, Thijs Koorman, Patrick W.B. Derksen

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Clinico-pathological characteristics of a distinct tumor phenotype: invasive lobular carcinoma with tubular elements (ILC-TE) in the WSG ADAPTcycle trial

    Clinico-pathological characteristics of a distinct tumor phenotype: invasive lobular carcinoma with tubular elements (ILC-TE) in the WSG ADAPTcycle trial 由 Martin Radner, Sandy Burmeister, Katarzyna Jóźwiak, Nora Schaumann, Malte Gronewold, Mieke Raap, Stephan Bartels, Henriette Christgen, Leonie Donata Kandt, Petra Hillmann, Ulrich Lehmann, Oleg Gluz, Monika Graeser, Sherko Kuemmel, Christine zu Eulenburg, Nadia Harbeck, Hans Kreipe, Matthias Christgen

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

    Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West Germa... 由 Ulrike Nitz, Oleg Gluz, Matthias Christgen, Ronald Kates, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Küemmel, Toralf Reimer, Andrea Stefek, Fatemeh Lorenz-Salehi, Petra Krabisch, Marianne Just, Doris Augustin, Cornelia Liedtke, Calvin Chao, Steven Shak, Rachel Wuerstlein, Hans Kreipe, Nadia Harbeck

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer

    Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer 由 Matthias Christgen, Oleg Gluz, Nadia Harbeck, Ronald Kates, Mieke Raap, Henriette Christgen, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Küemmel, Toralf Reimer, Andrea Stefek, Petra Krabisch, Marianne Just, Doris Augustin, Monika Graeser, Frederick L. Baehner, Rachel Wuerstlein, Ulrike Nitz, Hans Kreipe

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

    De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks... 由 Ulrike Nitz, Oleg Gluz, Matthias Christgen, E.‐M. Grischke, Doris Augustin, Sherko Küemmel, Michael Braun, Jochem Potenberg, A. Kohls, Katja Krauss, Andrea Stefek, Claudia Schumacher, Helmut Forstbauer, Toralf Reimer, Hans Holger Fischer, C Liedtke, Rachel Wuerstlein, Johannes Schumacher, Ronald Kates, H. Kreipe, Nadia Harbeck

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial

    Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐A... 由 Oleg Gluz, Cornelia Kolberg‐Liedtke, Aleix Prat, Matthias Christgen, Daniel Gebauer, Ronald Kates, Laia Paré, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Sherko Küemmel, Rachel Wuerstlein, Enrico Pelz, Ulrike Nitz, Hans Kreipe, Nadia Harbeck

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C

    The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C 由 Amelie de Gregorio, Wolfgang Janni, Thomas W. P. Friedl, Ulrike Nitz, Brigitte Rack, Andreas Schneeweiß, Ronald Kates, Tanja Fehm, Hans Kreipe, Matthias Christgen, Sherko Kümmel, Elisabeth Trapp, Rachel Wuerstlein, Andreas D. Hartkopf, Michael Clemens, Toralf Reimer, Lothar Häberle, Peter A. Fasching, Oleg Gluz, Nadia Harbeck

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/<i>ERBB2</i>-Positive Early Breast Cancer

    Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/<i>ERBB2</i>-Positive Early Breast Cancer 由 Oleg Gluz, Ulrike Nitz, Matthias Christgen, Sherko Küemmel, Johannes Holtschmidt, Johannes Schumacher, Andreas Hartkopf, Jochem Potenberg, Kerstin Luedtke‐Heckenkamp, Marianne Just, Christian Schem, Raquel von Schumann, Cornelia Kolberg‐Liedtke, Christine zu Eulenburg, Timo Schinköthe, Monika Graeser, Rachel Wuerstlein, Ronald Kates, Hans Kreipe, Nadia Harbeck

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

    Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic 由 Mitch Dowsett, Matthew J. Ellis, J. Michael Dixon, Oleg Gluz, J.F.R. Robertson, Ronald Kates, Vera J. Suman, Arran Turnbull, Ulrike Nitz, Matthias Christgen, Hans Kreipe, Sherko Küemmel, Judith M. Bliss, Peter Barry, Stephen Johnston, Samuel A. Jacobs, X. Cynthia, Ian E. Smith, Nadia Harbeck

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium

    Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium 由 Maxim De Schepper, Thijs Koorman, François Richard, Matthias Christgen, Anne Vincent‐Salomon, Stuart J. Schnitt, P. J. van Diest, Gitte Zels, Freya Mertens, Marion Maetens, Isabelle Vanden Bempt, Nadia Harbeck, Ulrike Nitz, Monika Gräser, Sherko Kümmel, Oleg Gluz, Birgit Weynand, Giuseppe Floris, Patrick W.B. Derksen, Christine Desmedt

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results

    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results 由 Oleg Gluz, Ulrike Nitz, Cornelia Liedtke, Matthias Christgen, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Nikola Bangemann, Christoph Lindner, Sherko Küemmel, Michael Clemens, Jochem Potenberg, Peter Staib, A. Kohls, Raquel von Schumann, Ronald Kates, Ronald Kates, Johannes Schumacher, Rachel Wuerstlein, Hans Kreipe, Nadia Harbeck

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: